Shuttleworth, Stephen,Hancox, Tim,Chuckowree, Irina,Folkes, Adrian
申请号：
AU2007246793
公开号：
AU2007246793B2
申请日:
2007.04.24
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
A thienopyrimidine of formula (I) and the pharmaceutically acceptable saltsthereof have activity as inhibitors of PI3K with selectivity for the P110 subtype,and may be used to treat diseases and disorders arising from abnormal cell growth,function or behaviour, particularly those associated with PI3 kinase such ascancer, immune disorders, cardiovascular disease, viral infection, inflammation,metabolism/endocrine disorders and neurological disorders. Processes forsynthesizing the compounds are also described.
